Known as promoter-proximal pausing, this interruption in the transcription activity of RNA polymerase II—the enzyme ...

Market to Reach $430 Million by 2032, Driven by Breakthrough Clinical Trials and Expanding Indications. The global RNA-Based Therape ...

Pfizer (PFE) stock and BioNTech (BNTX) stock in focus as FDA may not renew the authorization for their pediatric COVID shot. Read more here.

NIH director Jay Bhattacharya has offered a new explanation for why the federal government canceled $500 million in contracts ...

Researchers at Fred Hutch Cancer Center invented a new screening method called ReLiC that uses CRISPR-Cas9 to test all the ...

NIH Director Jay Bhattacharya offered an explanation for the cancellation of mRNA vaccine contracts that didn't align with ...

The government’s cancellation of almost $500 million in contracts involving mRNA vaccines could halt progress on cancer ...

In the video posted on X, Kennedy claimed mRNA vaccines were ineffective against mutated versions of the virus and revealed HHS is planning to reallocate the funding to research whole-virus vaccines, ...

Jerome Adams, the U.S. Surgeon General under President Trump's first term, is criticizing his administration's cuts to mRNA ...

Secretary Robert F. Kennedy Jr. said his department would slash funding for mRNA vaccine research and shift its focus to ...

Circular RNA may be part of the solution. Because circular RNA has no ends to degrade—unlike linear RNA—the molecule is more stable and its half-life is extended.